Man Group
PMVP icon

Man Group’s PMV Pharmaceuticals PMVP Stock Holding History

Man Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-62,048
Closed -$101K – 2155
2024
Q2 		$101K Sell
62,048
-52,384
-46% -$94.5K ﹤0.01% 1966
2024
Q1 		$195K Buy
+114,432
New +$214K ﹤0.01% 2014
2023
Q3 		– Sell
-41,800
Closed -$262K – 2098
2023
Q2 		$262K Buy
+41,800
New +$219K ﹤0.01% 1760
2023
Q1 		– Hold
0
– – – 1910

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Man Group's PMVP Position: Q3 2024 in Review

Man Group sold out of PMV Pharmaceuticals (PMVP) in Q3 2024, closing a stake of 62,048 shares — an estimated $101K sold.

Man Group first reported a position in PMVP in Q2 2023 and held it in 3 quarters. The position peaked at $262K in Q2 2023. 74 funds tracked by Wall St. Rank hold PMVP as of Q3 2024.

  • Man Group reported no remaining PMV Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Man Group sold 62,048 PMV Pharmaceuticals shares in Q3 2024, an estimated $101K.
  • Man Group first reported a position in PMV Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • Man Group's PMV Pharmaceuticals position peaked at $262K in Q2 2023.
  • 74 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2024.

Based on Man Group's 13F filing for Q3 2024, filed 14 Nov 2024.